BIOMATLANTE
-
Biologics
Biomatlante: A New Step Towards the MDR
NANTES, FRANCE (PRWEB) JULY 05, 2019 Just after BSI last January, TÜV Süd Product Service GmbH is now the second Notified…
Read More » -
Biologics
BIOMATLANTE receives MDSAP Accreditation
Nantes, France – Quality and Regulatory Biomatlante, a world leader in synthetic bone regeneration technologies, is pleased to announce the…
Read More » -
Biologics
Biomatlante Announces the Appointment of its New CEO
NANTES, FRANCE (PRWEB) FEBRUARY 01, 2019 Biomatlante, a world leader in synthetic bone regeneration technologies, is pleased to announce the appointment…
Read More » -
Biologics
Biomatlante Continues To Invest In Innovative Solutions For Active Healing Through Orthobiologics
NANTES, FRANCE (PRWEB) FEBRUARY 28, 2018 After the success of the European program REBORNE (FP7) focused on safety and efficacy of…
Read More » -
Biologics
Biomatlante invests in innovative solutions for active healing through orthobiologics
NANTES, FRANCE (PRWEB) DECEMBER 09, 2016 Coordinated by INSERM (Institut National de la Santé et de la Recherche Médicale) and…
Read More » -
Biologics
BIOMATLANTE Obtains CE Approval to Market EZ Cure Plug and Strip
BIOMATLANTE (Vigneux de Bretagne), a medical device company specialized in bone regeneration, today announced the CE regulatory approval of EZ…
Read More » -
Recon
BIOMATLANTE obtains CE approval to market its OSTEOTWIN™ Affix Sheath
BIOMATLANTE (Vigneux de Bretagne), a medical devices company specialized in bone regeneration, today announced the CE regulatory approval of OSTEOTWIN™…
Read More »